Propionic Acid

Propionic Acid

SCHEMBL990830

CCC(=O)O.[BiH3]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 175 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105246936-B Method for producing urethane (meth) acrylates 巴斯夫欧洲公司 2019-11-08 CN claimed
CN-102326076-B Chemical indicator compositions, indicators and methods 3M INNOVATIVE PROPERTIES CO. (US) 2016-06-01 CN claimed
US-9170245-B2 Chemical indicator composition, indicators and methods 3M INNOVATIVE PROPERTIES COMPANY (US) 2015-10-27 US claimed
US-8815066-B2 Coating composition with phosphorous-containing resins and organometallic compounds BASF COATINGS GMBH (DE) 2014-08-26 US claimed
EP-2506006-A1 Chemical indicator composition, indicators and methods 3M Innovative Properties Company (US) 2012-10-03 EP claimed
US-20110275159-A1 CHEMICAL INDICATOR COMPOSITION, INDICATORS AND METHODS 3M INNOVATIVE PROPERTIES COMPANY (US) 2011-11-10 US claimed
EP-2382461-A2 CHEMICAL INDICATOR COMPOSITION, INDICATORS AND METHODS 3M Innovative Properties Company (US) 2011-11-02 EP claimed
US-20110190173-A1 ACIDIC TREATMENT FLUIDS AND ASSOCIATED METHODS CASSIDY JUANITA M 2011-08-04 US claimed
WO-2010078422-A2 CHEMICAL INDICATOR COMPOSITION, INDICATORS AND METHODS 3M INNOVATIVE PROPERTIES COMPANY (US) 2010-07-08 WO claimed
WO-2009029539-A1 MIXTURES AND CATALYST SYSTEMS INCLUDING TRANSITION METAL-CONTAINING CATALYSTS AND NOBLE METAL-CONTAINING CATALYSTS, PROCESSES FOR THEIR PREPARATION, AND PROCESSES FOR THEIR USE IN OXIDATION REACTIONS MONSANTO TECHNOLOGY LLC (US) 2009-03-05 WO claimed
US-6565895-B2 Side-effect reduction of anti-cancer therapy GELTEX PHARMACEUTICALS, INC. 2003-05-20 US claimed
EP-1286676-A1 BISMUTH COMPOUNDS FOR THE TREATMENT AND PREVENTION OF MUCOSITIS Geltex Pharmaceuticals, Inc. (US) 2003-03-05 EP claimed
EP-1283841-A2 REACTION SYSTEMS FOR MAKING N-(PHOSPHONOMETHYL)GLYCINE COMPOUNDS Monsanto Technology LLC (US) 2003-02-19 EP claimed
EP-1242433-A2 USE OF A SUPPLEMENTAL PROMOTER IN CONJUNCTION WITH A CARBON-SUPPORTED, NOBLE-METAL-CONTAINING CATALYST IN LIQUID PHASE OXIDATION REACTIONS Monsanto Technology LLC (US) 2002-09-25 EP claimed
US-20020081340-A1 Bismuth compounds for the treatment and prevention of mucositis GELTEX PHARMACEUTICALS, INC. 2002-06-27 US claimed
US-20020068836-A1 Reaction systems for making N- (phosphonomethyl) glycine compounds MONSANTO COMPANY 2002-06-06 US claimed
US-20020016503-A1 Use of a supplemental promoter in conjunction with a carbon-supported, noble-metal containing catalyst in liquid phase oxidation reactions MONSANTO TECHNOLOGY LLC 2002-02-07 US claimed
WO-2001093878-A2 BISMUTH COMPOUNDS FOR THE TREATMENT AND PREVENTION OF MUCOSITIS GELTEX PHARMACEUTICALS, INC. (US) 2001-12-13 WO claimed
WO-2001092272-A2 REACTION SYSTEMS FOR MAKING N-(PHOSPHONOMETHYL)GLYCINE COMPOUNDS MONSANTO TECHNOLOGY LLC (US) 2001-12-06 WO claimed
WO-2001046208-A2 USE OF A SUPPLEMENTAL PROMOTER IN CONJUNCTION WITH A CARBON-SUPPORTED, NOBLE-METAL-CONTAINING CATALYST IN LIQUID PHASE OXIDATION REACTIONS MONSANTO TECHNOLOGY LLC (US) 2001-06-28 WO claimed